Oncology CME

Credits: 1.25 CME
Penn State College of Medicine
Achieving Innovation in CLL Care With BTK Inhibitors: Selection, Safety, and Sequencing Across the Disease Continuum
Philip A. Thompson, MB, MS / William G. Wierda, MD, PhD
September 30, 2020
Credits: 1.00 CME
Penn State College of Medicine
The Rise of Novel Antibodies in Multiple Myeloma: Exploring the Present and Future of Antibody-Based Treatment From CD38 to BCMA
Sagar Lonial, MD, FACP / Robert Z. Orlowski, MD, PhD
September 30, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Realizing the Potential of CDK 4/6 Inhibitor Therapy in Breast Cancer: An Examination of the Evidence That Is Informing Real-World Practice
Adam Brufsky, MD, PhD
September 30, 2020
Credits: 1.25 CME / CNE
Medical Learning Institute, Inc.
Targeting the RAS/MAPK Pathway in Neurofibromatosis Type 1, Plexiform Neurofibromas, and Optic Pathway Gliomas: Improving Patient Outcomes With an Innovative Therapeutic Approach
Concetta (Connie) DiDomenico, RN, MSN, PNP-BC, CPHON / Michael J. Fisher, MD
September 24, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Taking the Leap With Immunotherapy in Resectable Melanoma: Immune Checkpoint Inhibitors as Adjuvant and Neoadjuvant Therapy and Other Intersections With Surgical Management
Jennifer Wargo, MD, MMSc
September 23, 2020
Credits: 1.00 CNE
Medical Learning Institute, Inc.
Making Headway Toward Better Outcomes in Pancreatic Cancer: The Oncology Nurse as a Leader and Advocate for Patients in an Era of Advances in Care and Research
Gayle Jameson, RN, MSN, ACNP-BC, AOCN
September 22, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Making the Most of the New Era of Immuno-Oncology in TNBC: Essential Guidance for Surgeons on How to Maximize the Potential of Immunotherapies and Combinations in Advanced and Early-Stage Breast Cancer
George Plitas, MD
September 21, 2020
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Antibody Therapy in Acute Leukemia: Understanding Clinical Considerations for Use in Conjunction With HSCT
Professor David I. Marks
September 18, 2020
Credits: 1.25 CME / MOC / CNE
Medical Learning Institute, Inc.
The Era of Immuno-Oncology in TNBC: Navigating Evidence in Early-Stage and Advanced Disease, Practicalities of Integration, and Implications for Breast Surgeons
George Plitas, MD
August 28, 2020
Credits: 1.00 CME
Penn State College of Medicine
Perspectives on Innovative Treatment for B-Cell Malignancies
John M. Pagel, MD, PhD
August 25, 2020
Credits: 1.00 CME / MOC / CNE
Medical Learning Institute, Inc.
Building on Progress to Further Advance Care for Patients With EGFR Mutation–Positive NSCLC: A Look at Emerging Precision Medicine Strategies Encompassing Acquired Resistance, Treatment Sequencing, and Patient Considerations
Edward Garon, MD, MS
August 10, 2020
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Moving in Leaps and Bounds Toward Expanded Precision Treatment of HER2- or HER3-Driven Breast, Gastrointestinal, Lung, and Other Cancers: Current Challenges, Opportunities for Improvement, and Practical Considerations
Erika Hamilton, MD
August 6, 2020
Credits: 1.00 CNE
Medical Learning Institute, Inc.
Meeting the Many Challenges of AML: Oncology Nurse Tactics in an Era of Novel Therapies
Sara M. Tinsley, PhD, APRN, AOCN
August 6, 2020
Credits: 1.00 CNE
Medical Learning Institute, Inc.
Rethinking Patient Care in Endometrial and Cervical Cancer: How Nurses Can Lead the Targeted and Immunotherapeutic Revolution
Kimberly Halla, MSN, FNP-C
August 5, 2020
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
Modern Diagnostics and Targeted Therapy for TRK Fusion Cancers: Pathology-Oncologist Collaboration in the Era of Precision Medicine
George D. Demetri, MD
July 31, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Optimizing Precision Medicine in Gastric Cancer Care: Essential Guidance on Translating Scientific Advances With Novel HER2-Targeted Therapies and Other Agents Into Current Clinical Practice
Josep Tabernero, MD, PhD
July 27, 2020
Credits: 1.00 CME / MOC
Penn State College of Medicine
Evidence and Insights on Innovative Treatment for Bladder Cancer: Clinical Breakthroughs From Targeted and Immune Options to Antibodies and Gene Therapy
Arjun Balar, MD
July 27, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Evidence Informing Practice: Changing Standards of Care for Use of CDK4 and 6 Inhibitors in the Treatment of Breast Cancer
Joyce O’Shaughnessy, MD
July 23, 2020
Credits: 1.00 CME / MOC / CC / CNE / CPE
Medical Learning Institute, Inc.
It's Precisely the Time for More Precision in Genomic Testing and Targeted Treatment of NSCLC
Rebecca S. Heist, MD, MPH
July 23, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Targeting DNA Repair Defects Through PARP Inhibition in Prostate Cancer: Rationale, Evidence, and Clinical Implications
Emmanuel S. Antonarakis, MD
July 22, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Teaming Up to Improve Liver Cancer Outcomes Through Locoregional and Systemic Therapeutic Strategies: A Multidisciplinary Tumor Board Guiding Optimal Care for Patients Along the Intermediate to Advanced Disease Continuum
Matthew S. Johnson, MD, FSIR
July 22, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Harnessing the Immune System in the Treatment of Triple-Negative Breast Cancer to Maximize Benefits to Patients: State of the Science, Key Trials, Implications for Practice, and Patient-Centric Clinical Decision-Making
Heather L. McArthur, MD, MPH
July 22, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Optimizing Precision Medicine in Ovarian Cancer: Expert Insights on Clinical Implications of PARP Inhibitor Therapy and Companion Diagnostics
Bradley J. Monk, MD, FACS, FACOG
July 21, 2020
Credits: 1.00 CME / MOC
Penn State College of Medicine
How I Think, How I Treat: Understanding Innovation in Multiple Myeloma—New Models for Attacking Disease Across the Clinical Spectrum
Sagar Lonial, MD, FACP
July 17, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Practical Perspectives on Rapid Change in Endometrial and Cervical Cancer Management: Exploring Innovative Therapy in Gynecologic Malignancies
Linda R. Duska, MD, MPH
July 17, 2020
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
How I Think, How I Treat: BTK Inhibitors as a Centerpiece of Care for Hematologic Cancers
John C. Byrd, MD
July 16, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Following the Evidence to Effective Therapy for Myelofibrosis: How Clinicians Can Overcome Challenges in Patient Care in the JAK Inhibitor Era
Ruben A. Mesa, MD, FACP
July 14, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Everything You Need to Know About Biomarkers, Immunotherapies, Combinations, and Other Emerging Approaches for Lung Cancer
Suresh S. Ramalingam, MD, FACP, FASCO
July 14, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Patient Stories From the HCC CaseBook: Expert Guidance on Optimizing Outcomes and Care With Newly Available and Emerging Therapies
Richard S. Finn, MD
July 14, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Transforming Modern Care in AML: Clinical Solutions With Novel Agents for Diverse Patient Populations
Harry P. Erba, MD, PhD
July 10, 2020

Pages